Baxter agrees to sell vaccine business

SHARE Baxter agrees to sell vaccine business
baxter_headquarters.jpg

Baxter International Inc. has agreed to sell a cell-based technology for making vaccines to Nanotherapeutics Inc. Terms weren’t disclosed.

The Deerfield-based drugmaker is selling its Vero cell technology and related operations, including a production plant in Czech Republic. The cell technology is used in making flu vaccines as well as investigational vaccines for West Nile virus and others.

“The divestiture of the vaccines franchise will allow Baxter BioScience to enhance focus in core therapeutic areas of hematology, oncology and immunology, as it prepares to become an independent biopharmaceutical company,” said Ludwig Hantson, president of Baxter BioScience.

The Latest
A news release from NU Educators for Justice in Palestine, Student Liberation Union and Jewish Voice for Peace said the camp is meant to be “a safe space for those who want to show their support of the Palestinian people.”
Powerhouse showcase is part of a weekend of music events planned for Grant Park’s Festival Field great lawn, which also features previously announced sets by Keith Urban, the Chainsmokers, the Black Keys and Lauren Alaina.
Last year, Black and Brown residents, Muslim Americans, Jewish Americans, members of the LGBTQ+ community and others were targeted in hate crimes more than 300 times. Smart new policies, zero tolerance, cooperation and unity can defeat hate.
The city is willing to put private interests ahead of public benefit and cheer on a wrongheaded effort to build a massive domed stadium — that would be perfect for Arlington Heights — on Chicago’s lakefront.
Following its launch, the popular Mediterranean restaurant is set to open a second area outlet this summer in Vernon Hills.